Table 2. Prevalence (%) of trachoma and estimated TT cases in the Far North Region.
| District | No of children aged 1–9 years examined | TF in children aged 1–9 years (95% CI) | Active trachoma (TF&TI) in children aged 1–9 years (95% CI) | No of people ≥15 years examined | TT in people ≥15 years (95% CI) | TT in all ages (95% CI) | Estimated TT cases (95% CI) |
| Bogo | 1273 | 0.0 (0.0–0.3) | 0.0 (0.0–0.3) | 1228 | 0.1 (0.0–0.5) | 0.04 (0.01–0.23) | 38 (9–217) |
| Bourha* | 1936 | 10.1 (8.9–11.6) | 11.0 (9.6–12.4) | 1466 | 0.2 (0.1–0.6) | 0.09 (0.03–0.26) | 63 (22–187) |
| Goulfey* | 1509 | 11.1 (9.6–12.8) | 11.1 (9.6–12.8) | 1449 | 2.8 (2.0–3.7) | 1.39 (1.02–1.88) | 1011 (743–1370) |
| Guere | 1730 | 7.5 (6.4–8.9) | 7.6 (6.4–8.9) | 1188 | 1.2 (0.7–2.0) | 0.48 (0.29–0.80) | 556 (336–926) |
| Guidiguis* | 2299 | 16.9 (15.4–18.5) | 17.7 (16.2–19.3) | 1795 | 0.0 (0.0–0.2) | 0 (0.00–0.09) | 0 (0–147) |
| Hina* | 2083 | 21.6 (19.9–23.4) | 21.7 (20.0–23.5) | 1579 | 0.2 (0.1–0.6) | 0.08 (0.03–0.24) | 82 (30–242) |
| Kaele | 2028 | 1.2 (0.8–1.8) | 1.3 (0.9–1.9) | 2565 | 0.0 (0.0–0.2) | 0 (0.00–0.08) | 0 (0–93) |
| Kar Hay | 1694 | 0.5 (0.2–0.9) | 0.5 (0.2–0.9) | 1373 | 1.0 (0.6–1.7) | 0.46 (0.27–0.77) | 538 (318–907) |
| Kousseri* | 2003 | 12.5 (11.1–14.0) | 13.3 (11.9–14.9) | 1766 | 0.6 (0.4–1.1) | 0.42 (0.26–0.69) | 768 (470–1247) |
| Koza* | 1603 | 10.7 (9.3–12.3) | 20.5 (18.6–22.6) | 1783 | 0.1 (0.0–0.4) | 0.06 (0.02–0.22) | 100 (34–372) |
| Mada | 2089 | 1.8 (1.3–2.5) | 1.8 (1.3–2.5) | 1096 | 0.7 (0.4–1.4) | 0.25 (0.13–0.49) | 279 (145–545) |
| Maga | 2104 | 1.8 (1.3–2.4) | 1.8 (1.3–2.4) | 1758 | 0.1 (0.0–0.3) | 0.03 (0.00–0.15) | 44 (0–254) |
| Makary* | 1795 | 14.2 (12.6–15.8) | 14.8 (13.2–16.5) | 1450 | 4.1 (3.2–5.2) | 1.85 (1.44–2.37) | 2353 (1834–3018) |
| Maroua-Rural | 1787 | 8.7 (7.5–10.1) | 8.8 (7.6–10.2) | 1364 | 0.0 (0.0–0.3) | 0 (0.00–0.12) | 0 (0–272) |
| Maroua-Urban | 1815 | 4.4 (3.5–5.4) | 4.7 (3.9–5.8) | 1748 | 0.0 (0.0–0.2) | 0.03 (0.00–0.16) | 68 (0–386) |
| Meri* | 2207 | 33.1 (31.1–35.1) | 33.1 (31.1–35.1) | 2247 | 1.5 (1.1–2.1) | 0.76 (0.55–1.06) | 1515 (1091–2103) |
| Mindif | 640 | 0.0 (0.0–0.6) | 0.0 (0.0–0.6) | 959 | 0.0 (0.0–0.4) | 0 (0.00–0.24) | 0 (0–156) |
| Mogode* | 2073 | 20.0 (18.3–21.8) | 32.2 (30.3–34.3) | 1514 | 7.3 (6.1–8.7) | 3.12 (2.60–3.74) | 3210 (2673–3845) |
| Mokolo* | 2305 | 13.1 (11.7–14.5) | 18.0 (16.5–19.7) | 1746 | 5.3 (4.4–6.5) | 2.30 (1.88–2.80) | 4795 (3927–5849) |
| Mora | 1980 | 3.8 (3.0–4.7) | 4.3 (3.5–5.3) | 1759 | 0.1 (0.0–0.3) | 0.05 (0.01–0.19) | 89 (17–318) |
| Moulvoudaye | 940 | 0.0 (0.0–0.4) | 0.0 (0.0–0.4) | 1215 | 0.0 (0.0–0.3) | 0 (0.00–0.18) | 0 (0–178) |
| Moutourwa | 1836 | 6.3 (5.3–7.5) | 6.6 (5.6–7.8) | 1282 | 0.0 (0.0–0.3) | 0 (0.00–0.12) | 0 (0–51) |
| Pette* | 2216 | 23.1 (21.4–24.9) | 23.1 (21.4–25.0) | 1726 | 0.7 (0.4–1.2) | 0.30 (0.17–0.53) | 151 (84–263) |
| Roua* | 2014 | 25.5 (23.7–27.5) | 40.1 (38.0–42.3) | 1982 | 0.1 (0.0–0.3) | 0.03 (0.00–0.14) | 23 (0–127) |
| Tokombere* | 1817 | 42.5 (40.2–44.8) | 42.6 (40.3–44.9) | 1463 | 1.1 (0.7–1.8) | 0.49 (0.30–0.79) | 666 (410–1079) |
| Vele | 1637 | 2.7 (2.0–3.6) | 3.2 (2.4–4.1) | 1030 | 0.0 (0.0–0.4) | 0 (0.00–0.14) | 0 (0–111) |
| Yagoua | 1442 | 4.9 (3.9–6.2) | 5.0 (4.0–6.2) | 994 | 0.9 (0.5–1.7) | 0.37 (0.19–0.70) | 843 (434–1598) |
| Total | 48,844 | 11.2 (11.0–11.5) | 12.9 (12.6–13.2) | 41,533 | 1.0 (0.9–1.1) | 0.49 (0.44–0.53) | 17193 (12576–25860) |
*
HDs marked with a (*) qualify for district level MDA with azithromycin.